Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (7813)	1/28/2003 11:05:20 AM
From: Biomaven	Read Replies (2) \| Respond to of 52153

Crossy, <IMA> This is a very competitive sector that Inverness is playing in. A few years ago I followed the sector, but I no longer do. Be interesting to see a comparison with QDEL and Trinity biotech (forget what Trinity's symbol is - it used to be TRIBY) in terms of sales, margins and comparative market cap. I glanced at Trinity a few months back while back and it looked real cheap - stock was around $1.00 and they were marginally profitable if I recall correctly. Peter